Good morning and nice to see you again. Yet another pleasant is on the way and to celebrate, we are downing that mandatory cup of stimulation. And while the summer doldrums may be threatening, we expect this will be another busy day for digesting interesting information. So while you ready yourselves for meetings and deadlines, here are some tidbits to get you started. Have a great day...
Risperdal Fails To Help War Vets In PTSD Study (MSNBC)
Hedge Fund Offers $378M For Amag Pharmaceuticals (Bloomberg News)
NPS Pharma Amends Licensing Deal With Glaxo (Reuters)
Pfizer CEO Will Not Chase Large Deals (Bloomberg News)
Regulators Say International Pilot Program Was Successful (Pharma Times)
Vectura Gets New US Partner For Copy Of Lung Drug (Reuters)
EDITOR'S NOTE: Please check this post for updates throughout the morning